New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 2, 2014
06:34 EDTSTJSt. Jude Medical recommended ahead of HRS meeting at JPMorgan
JPMorgan recommends buying shares of St. Jude Medical ahead of next week's Heart Rhythm Society meeting. The firm expects the meeting to ease concerns surrounding Durata and it sees the potential for a CardioMEMS approval going into the meeting. JPMorgan reiterates an Overweight rating on St. Jude with a $74 price target.
News For STJ From The Last 14 Days
Check below for free stories on STJ the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 28, 2014
17:42 EDTSTJJ&J begins sales process for its medical device unit Cordis, WSJ says
Subscribe for More Information
August 26, 2014
16:29 EDTSTJSt. Jude Medical resolves FDA warning letter for Plano facility
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use